Lucira Health Inc. (LHDX:NASDAQ) soared at $0.51, a gain of 264.3%. On Mon, Feb 27, 2023, LHDX:NASDAQ hit a New 2-Week High of $0.51. The stock appeared on our News Catalysts scanner on Mon, Feb 27, 2023 at 11:55 AM in the 'BIOTECH' category. From Mon, Feb 13, 2023, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Mon, Feb 27, 2023 at $0.75 with a volume of 274M+.
About Lucira Health Inc. (LHDX:NASDAQ)
Lucira Health Inc is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits.
Top 10 Gainers:
- Lucira Health Inc. (LHDX:NASDAQ), 264.29%
- ContraFect Corporation (CFRX:NASDAQ), 52.9%
- Asset Entities Inc. (ASST:NASDAQ), 42.58%
- Concord Medical Services Holdings Limited (CCM:NYSE), 41.75%
- Decarbonization Plus Acquisition Corporation IV (DCRD:NASDAQ), 40.52%
- Peak Bio Inc Com (PKBO:NASDAQ), 39.13%
- Troika Media Group Inc. (TRKA:NASDAQ), 32.13%
- Benitec Biopharma Inc. (BNTC:NASDAQ), 30.55%
- Fisker Inc. Class A (FSR:NYSE), 30.28%
- Altisource Asset Management Corporation (AAMC:NYSEMKT), 25.6%